Latest kidney cancer news
NHS England campaign to combat fear of cancer
NHS England has launched a new campaign to tackle the [...]
ASCO GU 2022: Patient-reported experience of kidney cancer from the IKCC
The incidence of renal cell carcinoma (RCC) is rising globally, [...]
ASCO GU 2022: Choosing between combination treatments for advanced kidney cancer
Combination therapies have revolutionised the first-line treatment of metastatic clear [...]
ASCO GU 2022: Treatment of sarcomatoid kidney cancer with immunotherapy
Metastatic sarcomatoid clear cell RCC is an aggressive type of [...]
ASCO GU 2022: Cytoreductive nephrectomy for patients with lung metastases
Cytoreductive nephrectomy is the surgical removal of the tumour to [...]
ASCO GU 2022: Cytoreductive nephrectomy for patients with tumour thrombus
Cytoreductive nephrectomy is the surgical removal of the tumour to reduce the number [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo kidney cancer sunitinib cabozantinib Sutent progression-free survival NHS England biomarkers ipilimumab pembrolizumab Cabometyx axitinib COVID-19 cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus Yervoy risk factors adjuvant therapy Keytruda targeted therapy metastases papillary RCC everolimus biological markers ASCO Afinitor cancer outcomes first-line treatment NICEArchives
- 2025: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec